A weight-estimating tape with body-size correction was most accurate for dosing children
In a review of 250 studies, a length-based tape that adjusts for a child's build estimated weight and drug doses more accurately than the standard tape used in paediatric emergencies.
When a child collapses and needs emergency drugs, the dose depends on weight — and there is rarely time to put the child on a scale. A systematic review and meta-analysis published on 10 November in Pediatrics finds that a length-based tape which corrects for a child's body build estimated weight and calculated drug doses more accurately than the long-standard tape that does not [s1]. The finding speaks to a basic patient-safety problem in paediatric emergencies, though the review also exposes how little is known about whether better estimates change how children actually fare.
In a resuscitation, clinicians typically estimate a child's weight rather than measure it, because getting an accurate weight quickly is often impossible [s1]. The accuracy of the instruments used to do that estimating, and to turn it into a drug dose, is therefore a direct safety issue: an error in the estimate becomes an error in the dose [s1].
What the review did
Researchers systematically searched three databases — Embase, PubMed and the Cochrane Library — from inception to 19 December 2025 [s1]. They included systematic reviews, randomised controlled trials and non-randomised studies, and extracted each study's country, sample size, design and results [s1].
The question was specific: whether length-based tapes are better than other instruments for calculating drug doses, and whether they improve the accuracy of weight estimation, the time to give a drug, the accuracy of the dose, or clinical outcomes during resuscitation [s1]. The comparison that mattered most was between two length-based tapes — the widely used Broselow tape, and the PAWPER tape, which is also length-based but adds a correction for the child's body habitus, or build [s1].
What it found
The review included 250 studies in total, of which just 9 actually enrolled children who required resuscitation [s1]. That gap — hundreds of studies of the instruments, a handful in the emergency itself — is one of its central messages.
Where the two tapes were compared, the one that accounts for body build came out ahead. The PAWPER tape was superior to the Broselow tape for time to drug administration, for drug-dose accuracy and for weight-estimation accuracy in all analyses [s1]. In a direct paired meta-comparison of the proportion of estimates landing within 10% of true weight, the PAWPER tape beat the Broselow tape with an odds ratio of 2.48 (95% confidence interval 2.04 to 3.02) [s1]. Age-based formulas — the mental shortcuts that estimate weight from a child's age — were consistently inaccurate [s1].
The most important finding is what was missing. The review identified no studies at all of patient outcomes for the instruments used to calculate drug dosing during resuscitation [s1]. The evidence favours the habitus-corrected tape on accuracy, but accuracy is a proxy; whether it translates into children surviving or recovering better has not been tested.
How to read it
This is a large, systematic synthesis, and its accuracy conclusion is consistent across every analysis the reviewers ran: adding a correction for a child's build to a length-based tape improved weight estimates and the doses derived from them [s1]. That is a meaningful signal for a tool clinicians reach for in the worst moments, when there is no margin for a slow or wrong calculation.
The caveats are built into the evidence base itself. Only 9 of 250 studies took place in an actual resuscitation, so much of the data comes from simulations and convenience measurements rather than emergencies [s1]. And because no study measured whether more accurate dosing changed clinical outcomes, the review can say the instrument is more accurate but not that it saves more lives — a distinction that matters before any system overhauls its equipment on the strength of it [s1].
What to watch
The open question the authors leave is the outcomes question: whether length-based tapes with body-size correction, now favoured on accuracy, actually improve how children do after a resuscitation, which would take studies conducted in real emergencies rather than simulations [s1]. For context, see our coverage of patient safety and medical-device validation.
This article describes a single evidence review. It is not medical advice, and emergency drug dosing is a matter for trained clinicians and the protocols of the service providing care.
Sources
- Weight Estimation and Dose Calculation in Resuscitation: A Systematic Review and Meta-Analysis — Pediatrics , November 10, 2026
Croup: why one dose of steroid is the standard treatment
Croup gives young children a barking cough and noisy breathing. It is usually mild and self-limiting, and a single dose of oral steroid shortens it — with a low dose working about as well as a high one.
Drug treatment for a preterm heart-duct problem was linked to higher death risk
A Bayesian meta-analysis of 10 trials and 2,365 preterm infants tied drug treatment of the patent ductus arteriosus to a higher risk of death before 36 weeks, with no offsetting fall in lung disease.
Metformin in pregnancy was not linked to developmental delay in 177,409 children
A population-linked Australian cohort followed children to school entry after antenatal metformin. The adjusted relative risk of developmental vulnerability was 0.97 — no different from unexposed children.
Flat head in babies: the helmet worked no better than time in a trial
Positional flat head affects nearly half of two-month-olds and is usually mild. In the one randomised trial, moulding helmets matched the natural course — and every parent reported a side effect.